Overall rank by patents
#15,725
Across all tracked assignees
USPTO PatentsView assignee record - 19 granted patents across 6 technology areas, active 2016–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: F41B (WEAPONS FOR PROJECTING MISSILES WITHOUT USE OF EXPLOSIVE OR COMBUSTIBLE PROPELLANT CHARGE; WEAPONS NOT OTHERWISE PROVIDED FOR).
The verdict
Umarex holds 19 US patents across 6 technology areas, rank #15,725 of 50,000 tracked assignees.
Umarex USA, Inc. has been granted 19 US utility patents between 2016 and 2024, placing Umarex USA, Inc. at rank #15,725 across all assignees tracked by PlainPatent. This portfolio spans 6 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.7 claims per patent with primary concentration in F41B (WEAPONS FOR PROJECTING MISSILES WITHOUT USE OF EXPLOSIVE OR COMBUSTIBLE PROPELLANT CHARGE; WEAPONS NOT OTHERWISE PROVIDED FOR). As a US Corporation, Umarex USA, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Umarex sits between UHDE Inventa-fischer Gmbh (19 patents, rank #15,721) and Utsunomiya University (19 patents, rank #15,729) - the closest US assignees by grant volume. The composite Innovation Score of 34.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 9 grants, compared with 10 in the 2015–2019 window, a -10% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Umarex USA, Inc.'s 16.7 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 6 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Umarex USA, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
UHDE INVENTA-FISCHER GMBH
19 patents
ULC Robotics, Inc.
19 patents
ULTIZYME INTERNATIONAL LTD.
19 patents
ULTRA COMMUNICATIONS, INC.
19 patents
UNION CARBIDE CORPORATION
19 patents
UNIVERSIDADE FEDERAL DO RIO DE JANEIRO - UFRJ
19 patents
UNIVERSITY OF TECHNOLOGY SYDNEY
19 patents
UTSUNOMIYA UNIVERSITY
19 patents
UMAREX USA, INC.
19 patents
What this shows Umarex holds 19 patents at rank #15,725, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #15,725 in granted patent volume.
Other assignees with the most granted patents in Umarex's primary technology class.
Umarex's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
35 Top 52% higher than 48% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 4 | 21.1% |
| 2017 | 4 | 21.1% |
| 2019 | 2 | 10.5% |
| 2020 | 1 | 5.3% |
| 2021 | 3 | 15.8% |
| 2022 | 1 | 5.3% |
| 2023 | 2 | 10.5% |
| 2024 | 2 | 10.5% |
Top 6 of 6 technology areas
Overall rank by patents
#15,725
Across all tracked assignees
34.6 out of 100
How to use this portfolio
Umarex's 19 grants land it in the top 52% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.